Avadel Pharmaceuticals Reports First Quarter 2017 Results
May 09, 2017 11:31 am UTC| Business
DUBLIN, Ireland, May 09, 2017 -- Avadel Pharmaceuticals plc (NASDAQ:AVDL) today announced its financial results for the first quarter of 2017. Highlights Include: Total revenues for the first quarter 2017 were $52.5...
ABcann Extends Agreement With Medical Cannabis Pioneer
May 09, 2017 11:31 am UTC| Business
OTTAWA, May 09, 2017 -- ABcann Global Corporation (TSX-V:ABCN) (the “Company”) is pleased to announce that Raphael Mechoulam has agreed to extend his role as an advisor to the Company. Mechoulam is an Israeli Organic...
ABcann Extends Agreement With Medical Cannabis Pioneer
May 09, 2017 11:31 am UTC| Business
OTTAWA, May 09, 2017 -- ABcann Global Corporation (TSX-V:ABCN) (the “Company”) is pleased to announce that Raphael Mechoulam has agreed to extend his role as an advisor to the Company. Mechoulam is an Israeli Organic...
May 09, 2017 11:31 am UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, May 09, 2017 -- Altisource Residential Corporation (“RESI” or the “Company”) (NYSE:RESI) today announced financial and operating results for the first quarter of 2017. First Quarter...
May 09, 2017 11:31 am UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, May 09, 2017 -- Altisource Residential Corporation (“RESI” or the “Company”) (NYSE:RESI) today announced financial and operating results for the first quarter of 2017. First Quarter...
Spark Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Progress
May 09, 2017 11:31 am UTC| Business
Work on U.S. Biologics License Application (BLA) for investigational voretigene neparvovec is complete Interim results fromSPK-7001Phase 1/2 clinical trial in choroideremiareported; continuing enrollment targeting...
Spark Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Progress
May 09, 2017 11:31 am UTC| Business
Work on U.S. Biologics License Application (BLA) for investigational voretigene neparvovec is complete Interim results fromSPK-7001Phase 1/2 clinical trial in choroideremiareported; continuing enrollment targeting...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes